Enanta Pharmaceuticals
ENTA
#8720
Rank
HK$1.74 B
Marketcap
HK$59.73
Share price
-4.51%
Change (1 day)
-39.71%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2026 (TTM): -HK$18.82

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$18.89. In 2025 the company made an earnings per share (EPS) of -HK$25.08 an increase over its 2024 EPS that were of -HK$38.80.

EPS history for Enanta Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$18.82-24.97%
2025-HK$25.08-35.35%
2024-HK$38.80
2021-HK$39.0472.92%
2020-HK$22.58-267.44%
2019HK$13.48-61.35%
2018HK$34.88147.22%
2017HK$14.11-460%
2016-HK$3.92-114.88%
2015HK$26.34-23.81%
2014HK$34.57-244.12%
2013-HK$23.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36-377.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.15-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
HK$45.87-342.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$122.84-750.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78-141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.43-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA